BL
AMED

BFSG LLC’s Amedisys AMED Stock Holding History

BFSG LLC’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,562
Closed -$445K – 94
2018
Q3 		$445K Buy
+3,562
New +$393K 0.19% 107

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFSG LLC's AMED Position: Q4 2018 in Review

BFSG LLC sold out of Amedisys (AMED) in Q4 2018, closing a stake of 3,562 shares — an estimated $445K sold.

BFSG LLC first reported a position in AMED in Q3 2018 and held it in 1 quarter. The position peaked at $445K in Q3 2018. 297 funds tracked by Wall St. Rank hold AMED as of Q4 2018.

  • BFSG LLC reported no remaining Amedisys position as of Q4 2018 after selling out during the quarter.
  • BFSG LLC sold 3,562 Amedisys shares in Q4 2018, an estimated $445K.
  • BFSG LLC first reported a position in Amedisys in Q3 2018 and held it in 1 quarter.
  • BFSG LLC's Amedisys position peaked at $445K in Q3 2018.
  • 297 funds tracked by Wall St. Rank held Amedisys as of Q4 2018.

Based on BFSG LLC's 13F filing for Q4 2018, filed 24 Jan 2019.